The Bluest of Blue Chips

  • Investing in the most dominant health care company in the world.
  • Over the last two decades JNJ has trounced the market, and with lower risk. Will this trend continue?
  • With a AAA credit rating and 54 straight years of dividend hikes, should JNJ be the focal point of your portfolio?
  • Are there any potential negatives on the horizon for this extraordinary company?